Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Natalizumab in the pediatric MS population: results of the Italian registry.
The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
Evidence for classic complement activity in neuromyelitis optica.
Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease.
Lingo-1 Inhibited by RNA Interference Promotes Functional Recovery of Experimental Autoimmune Encephalomyelitis.
Mesenchymal Stem Cell-Based Therapy in a Mouse Model of Experimental Autoimmune Encephalomyelitis (EAE).
Low and High CD8 Positive T cells in Multiple Sclerosis Patients.
Observational Study Assessing Demographic, Economic and Clinical Factors Associated with Access and Utilization of Health Care Services of Patients with Multiple Sclerosis under Treatment with Interferon Beta-1b (EXTAVIA).
Cognitive impairment in Chinese neuromyelitis optica.
Enrichment of Oligodendrocyte Progenitors from Differentiated Neural Precursors by Clonal Sphere Preparations.
[Translation and cross-cultural adaptation of the Multiple Sclerosis Walking Scale (MSWS-12) into Brazilian Portuguese].
[Neuromyelitis optica in children. Two case reports.]
What is needed to keep persons with multiple sclerosis vitamin D-sufficient throughout the year?
The impact of osteopontin gene variations on multiple sclerosis development and progression.
Hemianopia and visual loss due to progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis.
Distress associated with patients' symptoms and depression in a sample of Mexican caregivers of individuals with MS.
Expansion of Functional Human Mucosal-Associated Invariant T Cells via Reprogramming to Pluripotency and Redifferentiation.
Management of Secondary Progressive Multiple Sclerosis: Prophylactic Treatment-Past, Present, and Future Aspects.
Procedural Variations in the Stroop and the Symbol Digit Modalities Test: Impact on Patients with Multiple Sclerosis.
Risk of relapse phenotype recurrence in multiple sclerosis.
Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors.
Disability Identity Predicts Lower Anxiety and Depression in Multiple Sclerosis.
Epigenetic changes in neurology: DNA methylation in multiple sclerosis.
CENTENARIAN RATES AND LIFE EXPECTANCY RELATED TO THE DEATH RATES OF MULTIPLE SCLEROSIS, ASTHMA AND RHEUMATOID ARTHRITIS AND THE INCIDENCE OF TYPE 1 DIABETES IN CHILDREN.
The Latest Innovations in the Drug Pipeline for Multiple Sclerosis.
Pages
« first
‹ previous
…
292
293
294
295
296
297
298
299
300
…
next ›
last »